<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:department>Sch of Life Sciences</gtr:department><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6801518B-C8E0-47A7-B97F-836705903CA0"><gtr:id>6801518B-C8E0-47A7-B97F-836705903CA0</gtr:id><gtr:firstName>Keith</gtr:firstName><gtr:surname>Caldecott</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FF013930%2F1"><gtr:id>1EC4B90A-1FED-429B-A2EB-1C44DD787246</gtr:id><gtr:title>Functional Characterisation of APLF; A Novel Human Protein Involved in the Cellular Response to Chromosomal DNA Strand Breaks</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/F013930/1</gtr:grantReference><gtr:abstractText>The DNA in our cells is damaged more than 10,000 times per cell per day. If not repaired properly, this damage can result in genetic mutations and/or cell death. Consequently, cells have evolved a number of sophisticated biochemical mechanisms by which damaged DNA is rapidly detected and repaired. Recently, my group identified a completely novel human DNA repair protein that we denoted Aprataxin and PNK-Like Factor, or APLF. We have discovered that APLF is important for ensuring that breaks in one or both strands of DNA are repaired as fast as possible. Here, we plan to characterise in detail the importance of APLF for genetic integrity and genetic stability in living cells and in animals. In addition, we will identify the biochemical function of APLF and integrate this role into our model for how DNA strand breaks are repaired in human cells.</gtr:abstractText><gtr:technicalSummary>DNA strand breaks are a major threat to cell survival and genetic integrity. Single-strand breaks (SSBs) arise from a variety of sources including oxidative stress and are the commonest DNA lesions arising in cells (tens of thousands per cell per day). If not repaired, SSBs can block transcription and can be converted into potentially clastogenic or lethal DNA double-strand breaks (DSBs) during DNA replication. Recently, we identified an uncharacterized open reading frame (C2orf13) that encodes a novel human protein that we denoted Aprataxin and PNK-Like Factor (APLF), based on its sequence similarity to the single-strand break repair (SSBR) and double-strand break repair (DSBR) proteins Aprataxin and PNK. Our preliminary experiments have demonstrated that, similar to Aprataxin and PNK, APLF is recruited into the SSBR and DSBR machinery through CK2-mediated phosphorylation-dependent interactions with the scaffold proteins XRCC1 and XRCC4, respectively. Moreover, these experiments revealed that APLF rapidly accumulates at sites of DNA strand breakage in human cells and that depletion of APLF significantly reduces rates of both SSBR and DSBR following oxidative stress or ionizing radiation. These data identify APLF as an exciting new component of the cellular response to DNA damage. In the current proposal we will examine the phenotype of cells lacking and/or depleted of APLF and characterise the function of this exciting new protein at the biochemical, cellular, and physiological level.</gtr:technicalSummary><gtr:fund><gtr:end>2011-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2008-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>404340</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Programme Grant (2013)</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>4E231775-34C4-4833-9CE0-AE44C53535FB</gtr:id><gtr:outcomeId>kq3tdK9PaVb</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>the findings from this work led to a publication in molecular cell and in part formed the basis of a successful programme grant application to CRUK</gtr:description><gtr:firstYearOfImpact>2011</gtr:firstYearOfImpact><gtr:id>DAB54626-4CF4-4EC7-9705-8A67409FD2E4</gtr:id><gtr:impactTypes/><gtr:outcomeId>545bffc12c81f9.29951236</gtr:outcomeId></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>we identified and characterised the role of a novel protein component in the repair of broken chromosomes</gtr:description><gtr:exploitationPathways>the understanding gleamed from this work raises new possible candidates for therapeutic intervention in cancer therapy.Moroever, it has opened up new avenues of mechanistic understanding in DSB repair</gtr:exploitationPathways><gtr:id>9AFB16C9-4500-4D68-BEDE-EE5AEF6736F3</gtr:id><gtr:outcomeId>545c00a91df736.14794272</gtr:outcomeId><gtr:sectors><gtr:sector>Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>98FBAB60-8726-4A43-9830-2DD8B60A4556</gtr:id><gtr:title>APLF promotes the assembly and activity of non-homologous end joining protein complexes.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee1a81c67f608df4032a7745d1359901"><gtr:id>ee1a81c67f608df4032a7745d1359901</gtr:id><gtr:otherNames>Grundy GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>pm_15157_27_23178593</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6BEDF9F-42B0-4C36-9694-3ADE278231C1</gtr:id><gtr:title>Versatility in phospho-dependent molecular recognition of the XRCC1 and XRCC4 DNA-damage scaffolds by aprataxin-family FHA domains.</gtr:title><gtr:parentPublicationTitle>DNA repair</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/855494b73557f7c432cdf41869f3cb18"><gtr:id>855494b73557f7c432cdf41869f3cb18</gtr:id><gtr:otherNames>Cherry AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1568-7856</gtr:issn><gtr:outcomeId>56d6022d4414c5.27309396</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3ECC09B-7695-4266-BEE5-CBC406282554</gtr:id><gtr:title>PARP-3 and APLF function together to accelerate nonhomologous end-joining.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b65e5c2f5cfc13c162afd004ca52889"><gtr:id>9b65e5c2f5cfc13c162afd004ca52889</gtr:id><gtr:otherNames>Rulten SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>545c02666bace0.59785377</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/F013930/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>